Tg Therapeutics (TGTX)

$29.33 +0.37 (1.28%)
Market Cap 4.49B
Revenue (ttm) 329.00M
Net Income (ttm) 23.38M
EPS (ttm) N/A
PE Ratio 77.11
Forward PE 37.13
Profit Margin 7.11%
Debt to Equity Ratio 0.89
Volume 1,818,098
Avg Vol 2,127,386
Day's Range N/A - N/A
Shares Out 158.67M
Stochastic %K 67%
Beta 1.95
Analysts Strong Sell
Price Target $40.50

Company Profile

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's de...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 554 4484
Fax: 212 554 4531
Address:
3020 Carrington Mill Blvd., Suite 475, Morrisville, United States
Lions1_83
Lions1_83 Aug. 29 at 9:10 PM
$TGTX Not a bad week . Let's have a little follow thru next week Have a good weekend all Enjoy the holiday .🇺🇸
0 · Reply
StockDreamin
StockDreamin Aug. 29 at 8:40 PM
$TGTX i like it
0 · Reply
Ttubular
Ttubular Aug. 29 at 8:04 PM
$TGTX lately it’s been a roller coaster ride all day till the end. Then we have a have a late day surge up. I will take being green everyday but once in awhile can we have a $1+ Green Day!! Please!!!!
1 · Reply
ern1in
ern1in Aug. 29 at 8:01 PM
$TGTX yahoo close > 29.33 ...... Not bad .
0 · Reply
CloudMatt
CloudMatt Aug. 29 at 7:58 PM
$TGTX Bought more
0 · Reply
FUDrucker100
FUDrucker100 Aug. 29 at 7:58 PM
$TGTX Have a good weekend, long and strong BULLS!
0 · Reply
MJStock
MJStock Aug. 29 at 7:51 PM
$TGTX push.
1 · Reply
Ttubular
Ttubular Aug. 29 at 7:49 PM
$TGTX another late day surge
0 · Reply
uhk_it_im_in
uhk_it_im_in Aug. 29 at 7:43 PM
$TGTX 👀
0 · Reply
CedarPark
CedarPark Aug. 29 at 7:23 PM
$TGTX looks like we have been slowly drifting higher this week as opposed to dropping the last 2 weeks before. Good to see some nibbling and accumulation going on here. BUY. We should get back over $30 next week.
0 · Reply
Latest News on TGTX
TG Therapeutics to Participate in the Cantor Global Healthcare Conference

Aug 28, 2025, 8:00 AM EDT - 1 day ago

TG Therapeutics to Participate in the Cantor Global Healthcare Conference

TG Therapeutics, Inc. (TGTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 10:19 AM EDT - 25 days ago

TG Therapeutics, Inc. (TGTX) Q2 2025 Earnings Call Transcript

TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance

Aug 4, 2025, 7:00 AM EDT - 25 days ago

TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance

TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update

Jul 30, 2025, 7:30 AM EDT - 4 weeks ago

TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update

TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel

Jun 25, 2025, 4:05 PM EDT - 2 months ago

TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel

Evercore ISI's Julian Emanuel says now is the time to buy small-caps

Jun 9, 2025, 4:51 PM EDT - 2 months ago

Evercore ISI's Julian Emanuel says now is the time to buy small-caps

CNS LEU RMBS SFM

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Jun 6, 2025, 7:30 AM EDT - 3 months ago

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

TG Therapeutics: Estimates Could Soon Be Raised Again

May 28, 2025, 6:00 AM EDT - 3 months ago

TG Therapeutics: Estimates Could Soon Be Raised Again

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting

May 27, 2025, 7:30 AM EDT - 3 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting

TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show

May 5, 2025, 4:37 PM EDT - 4 months ago

TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show

TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges

May 5, 2025, 1:30 PM EDT - 4 months ago

TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges

TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript

May 5, 2025, 10:55 AM EDT - 4 months ago

TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

May 5, 2025, 7:00 AM EDT - 4 months ago

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update

Apr 30, 2025, 7:30 AM EDT - 4 months ago

TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Apr 10, 2025, 7:30 AM EDT - 5 months ago

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

Apr 7, 2025, 7:30 AM EDT - 5 months ago

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher

Mar 21, 2025, 11:50 AM EDT - 5 months ago

Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel

Mar 15, 2025, 8:42 AM EDT - 5 months ago

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel

TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials

Mar 14, 2025, 2:04 PM EDT - 6 months ago

TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials

TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter

Mar 12, 2025, 4:11 PM EDT - 6 months ago

TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Mar 7, 2025, 7:30 AM EST - 6 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025

Mar 4, 2025, 7:03 AM EST - 6 months ago

Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025

CORT GILD PRVA TKO

TG Therapeutics: A Wonderful Hold

Mar 3, 2025, 3:59 PM EST - 6 months ago

TG Therapeutics: A Wonderful Hold

TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 11:55 AM EST - 6 months ago

TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Feb 27, 2025, 7:30 AM EST - 6 months ago

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

Feb 26, 2025, 7:30 AM EST - 6 months ago

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset'

Feb 18, 2025, 10:20 AM EST - 6 months ago

20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset'

ARWR AUB CRK CYTK EXE KRYS MARA

TG Therapeutics: Entering 2025 With Increased Investor Expectations

Jan 23, 2025, 2:48 PM EST - 7 months ago

TG Therapeutics: Entering 2025 With Increased Investor Expectations

TG Therapeutics: 2025 Revenues Will Smash Expectations

Jan 21, 2025, 2:17 AM EST - 7 months ago

TG Therapeutics: 2025 Revenues Will Smash Expectations

TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst

Jan 13, 2025, 11:38 PM EST - 8 months ago

TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 9, 2025, 7:30 AM EST - 8 months ago

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

20 stocks likely to lag the S&P 500 over the next year — for this one reason

Dec 4, 2024, 7:36 AM EST - 9 months ago

20 stocks likely to lag the S&P 500 over the next year — for this one reason

CELH CENX CNXC CRSR CXM FLG GEO

TG Therapeutics to Participate in the Evercore HealthCONx Conference

Nov 29, 2024, 8:00 AM EST - 9 months ago

TG Therapeutics to Participate in the Evercore HealthCONx Conference

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Nov 21, 2024, 6:00 AM EST - 10 months ago

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates

Nov 5, 2024, 1:50 PM EST - 10 months ago

TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates

TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here's Why Shares Fell

Nov 4, 2024, 8:27 PM EST - 10 months ago

TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here's Why Shares Fell

TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 11:16 AM EST - 10 months ago

TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript

FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics

Nov 4, 2024, 9:00 AM EST - 10 months ago

FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

Nov 1, 2024, 8:06 AM EDT - 10 months ago

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

TG Therapeutics: A Look At New Briumvi Data And Ocrevus Zunovo Approval

Sep 22, 2024, 8:17 AM EDT - 1 year ago

TG Therapeutics: A Look At New Briumvi Data And Ocrevus Zunovo Approval

New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis

Sep 18, 2024, 7:15 AM EDT - 1 year ago

New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis

New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment

Sep 18, 2024, 7:00 AM EDT - 1 year ago

New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

Sep 5, 2024, 7:30 AM EDT - 1 year ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

TG Therapeutics Delivers A Beat-And-Raise Q2 And A $100 Million Buyback

Aug 7, 2024, 4:59 AM EDT - 1 year ago

TG Therapeutics Delivers A Beat-And-Raise Q2 And A $100 Million Buyback

TG Therapeutics, Inc. (TGTX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 3:12 PM EDT - 1 year ago

TG Therapeutics, Inc. (TGTX) Q2 2024 Earnings Call Transcript

HealthCare Royalty and Blue Owl Announce $250M Debt Financing with TG Therapeutics

Aug 6, 2024, 9:01 AM EDT - 1 year ago

HealthCare Royalty and Blue Owl Announce $250M Debt Financing with TG Therapeutics

TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update

Aug 5, 2024, 7:30 AM EDT - 1 year ago

TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update

TG Therapeutics: Pressure On Briumvi To Perform As Share Price Hits Resistance

Jul 30, 2024, 5:00 AM EDT - 1 year ago

TG Therapeutics: Pressure On Briumvi To Perform As Share Price Hits Resistance

TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Jun 7, 2024, 7:50 AM EDT - 1 year ago

TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

Jun 3, 2024, 7:30 AM EDT - 1 year ago

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

Lions1_83
Lions1_83 Aug. 29 at 9:10 PM
$TGTX Not a bad week . Let's have a little follow thru next week Have a good weekend all Enjoy the holiday .🇺🇸
0 · Reply
StockDreamin
StockDreamin Aug. 29 at 8:40 PM
$TGTX i like it
0 · Reply
Ttubular
Ttubular Aug. 29 at 8:04 PM
$TGTX lately it’s been a roller coaster ride all day till the end. Then we have a have a late day surge up. I will take being green everyday but once in awhile can we have a $1+ Green Day!! Please!!!!
1 · Reply
ern1in
ern1in Aug. 29 at 8:01 PM
$TGTX yahoo close > 29.33 ...... Not bad .
0 · Reply
CloudMatt
CloudMatt Aug. 29 at 7:58 PM
$TGTX Bought more
0 · Reply
FUDrucker100
FUDrucker100 Aug. 29 at 7:58 PM
$TGTX Have a good weekend, long and strong BULLS!
0 · Reply
MJStock
MJStock Aug. 29 at 7:51 PM
$TGTX push.
1 · Reply
Ttubular
Ttubular Aug. 29 at 7:49 PM
$TGTX another late day surge
0 · Reply
uhk_it_im_in
uhk_it_im_in Aug. 29 at 7:43 PM
$TGTX 👀
0 · Reply
CedarPark
CedarPark Aug. 29 at 7:23 PM
$TGTX looks like we have been slowly drifting higher this week as opposed to dropping the last 2 weeks before. Good to see some nibbling and accumulation going on here. BUY. We should get back over $30 next week.
0 · Reply
gellerm21
gellerm21 Aug. 29 at 7:20 PM
$TGTX How about they allow us a small victory of >= $29 before the holiday. Just a bit of hope and relief.
1 · Reply
Cedenmo
Cedenmo Aug. 29 at 6:57 PM
$TGTX does MW remain CEO if this isn’t $10B market cap by June, or is he gone?
3 · Reply
JinxyBio
JinxyBio Aug. 29 at 6:28 PM
$TGTX
0 · Reply
wetsalmon
wetsalmon Aug. 29 at 5:40 PM
$TGTX As usual…. No fear.
1 · Reply
lpcongas99
lpcongas99 Aug. 29 at 5:34 PM
$TGTX other than BABA this is the strongest looking stock on my screen today
0 · Reply
Quad_
Quad_ Aug. 29 at 4:33 PM
$TGTX Oh please oh please oh please... give us $29. Chartist? Work your magic! MW? Be good at Cantor. Trump? Take a vacation.
1 · Reply
Chartist0_0
Chartist0_0 Aug. 29 at 2:39 PM
$TGTX back to 45 plus by Halloween.
1 · Reply
buylowandwait
buylowandwait Aug. 29 at 2:33 PM
$TGTX Blue chip defensive stock nowadays !
1 · Reply
financiern
financiern Aug. 29 at 2:31 PM
$TGTX
0 · Reply
BobMacDTruck
BobMacDTruck Aug. 29 at 2:01 PM
$TGTX not sure why MW does these at this point in the company. Never seems to help the stock price.
2 · Reply
Rickerthestockpicker1
Rickerthestockpicker1 Aug. 29 at 12:27 PM
$TGTX Always Very Very
0 · Reply
StockDreamin
StockDreamin Aug. 29 at 11:54 AM
$TGTX cmon cmon
1 · Reply